---
title: "Canaan Inc. Stock 12‑Month Price Target Cut to $1.91, Implies 295% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286956881.md"
description: "Canaan Inc.'s average stock price target has been reduced from $2.05 to $1.91, with estimates ranging from $1 to $3 per share. This new target suggests a potential upside of approximately 295% based on the May 18 closing price. The consensus rating remains a 'Buy' from 7 analysts, with 6 Buys and 1 Hold."
datetime: "2026-05-19T19:20:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286956881.md)
  - [en](https://longbridge.com/en/news/286956881.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286956881.md)
---

# Canaan Inc. Stock 12‑Month Price Target Cut to $1.91, Implies 295% Upside

-   According to estimates from 7 analysts, Canaan Inc. stock's average price target has fallen from $2.05 to $1.91, with forecasts ranging from $1 to $3 per share
-   Based on the May 18 closing price, the updated target implies approximately 295% potential upside
-   Consensus rating remains at “Buy” across 7 covering analysts, with 6 Buys, 1 Holds and 0 Sells

Explore more price target data and ratings for Canaan Inc. on the , and track all previous and future analyst recommendations for Canaan Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [CAN.US](https://longbridge.com/en/quote/CAN.US.md)

## Related News & Research

- [Canaan Inc. Wins Competitive Bid to Provide Hash-to-Heat Equipment to Nordic District Heating Network | CAN Stock News](https://longbridge.com/en/news/286894364.md)
- [Singapore's Canaan Q1 revenue falls, hurt by bitcoin price decline](https://longbridge.com/en/news/286896698.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4](https://longbridge.com/en/news/286958909.md)